249420.KS · 일동제약

South Korea · RS rating 4 · As of 2026-10-14

Price13,270.00 KRW
1-day change+0.9%
RS rating (overall / 1M / 3M / 12M)4 / 9 / 18 / 14
StageDeclining
Composite / Minervini / CANSLIM score21 / 8 / 31
Industry group (rank)Medical-Generic Drugs (76)
EPS growth Q/Q-30.9%
Sales growth Q/Q+4.1%
Distance from 52-week high+70.0%
Market cap (USD)$329.0M
Open South Korea in the interactive screener